Allianz Asset Management
VYNT

Allianz Asset Management’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Allianz Asset Management’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-903
Closed -$1.06M – 2532
2015
Q3 		$1.06M Buy
903
+5
+0.6% +$7.66K ﹤0.01% 1806
2015
Q2 		$1.58M Buy
+898
New +$1.4M ﹤0.01% 1799

Other funds holding VYNT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QGM
Quality Growth Management Rancho Santa Fe, California $88.9M AUM
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

Allianz Asset Management's VYNT Position: Q4 2015 in Review

Allianz Asset Management sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q4 2015, closing a stake of 903 shares — an estimated $1.06M sold.

Allianz Asset Management first reported a position in VYNT in Q2 2015 and held it in 2 quarters. The position peaked at $1.58M in Q2 2015. 40 funds tracked by Wall St. Rank hold VYNT as of Q4 2015.

  • Allianz Asset Management reported no remaining Vyant Bio, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Allianz Asset Management sold 903 Vyant Bio, Inc. Common Stock shares in Q4 2015, an estimated $1.06M.
  • Allianz Asset Management first reported a position in Vyant Bio, Inc. Common Stock in Q2 2015 and held it in 2 quarters.
  • Allianz Asset Management's Vyant Bio, Inc. Common Stock position peaked at $1.58M in Q2 2015.
  • 40 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q4 2015.

Based on Allianz Asset Management's 13F filing for Q4 2015, filed 16 Feb 2016.